ULTRA (Uterine Leiomyoma Treatment with Radiofrequency Ablation)

Slides:



Advertisements
Similar presentations
Chiari Surgical Outcomes Trial PI: Bermans J. Iskandar and Timothy George with collaboration from John Kestle ASAP-funded pilot study ASAP-funded pilot.
Advertisements

Factors associated with post-operative follow-up after voluntary medical male circumcision in Nyanza Province, Kenya Arbogast Oyanga Family AIDS Care and.
INTRODUCING THE RELIEF REGISTRY Dr. Jaron Rabinovici Sheba Medical Center, Israel.
The effect of changes in Kenya HIV guidelines on proportion of patients on ART and patient characteristics at initiation in Lumumba Health Centre, Western.
SF Coordinating Center Multicenter Trials Industry-sponored Trials Pilot Studies Steve Cummings, MD Director, SF Coordinating Center.
Role of Hysteroscopy in Diagnosis and Treatment of Infertility Factors M.E.Parsanezhad M.D Professor and chair Department of Gynecology & Obstetrics Head.
FOCUS ON NLM RESOURCES: CLINICALTRIALS.GOV. WHAT IS A CLINICAL STUDY?  Research study using human subjects.  Volunteers may have a certain disease or.
Alzheimer’s Disease Neuroimaging Initiative STEERING COMMITTEE April
Clinician Practices in Assessing Risk Behavior in US HIV Clinics Carol Dawson Rose, Grant Colfax, Lisa Metsch, David Mc Kirnan and Cari Courtenay-Quirk.
HIV INTERVENTION FOR PROVIDERS (HIP) Principal Investigators:  Carol Dawson Rose, RN, Ph.D. and Grant Colfax, MD. Co-Investigators:  Cynthia Gomez, Ph.D.,
Factors associated with post-operative follow-up after voluntary medical male circumcision in Nyanza Province, Kenya Arbogast Oyanga Monitoring and Evaluation(M&E)
Medical Research BADRAG meeting Jan 2013 Dr H Sari-Kouzel.
BAD Biologic Interventions Register (BADBIR ) An update November 2010.
11 February 2008NLM BOR WG on Clinical Trials1 Clinical Trials Registration and Results Reporting: Legislative Requirements Jerry Sheehan Assistant Director.
Yesterday, today, and tomorrow
Nelly Burdette, Psyd Director, Integrated Behavioral Health, PCHC Integrated Behavioral Health Practice Facilitator, CTC MHI Faculty Advisor, HMS Center.
ACRIN 6673 Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in Cirrhotic Patients: A Multi-Center Study.
SF Coordinating Center Multicenter Trials Pilot Studies Steve Cummings, MD.
Thesis project of Dave Walton PT, PhD(cand.).  To develop a new tool for use with acute WAD patients that: 1.Is clinically feasible 2.Provides an estimate.
In the name of GOD the Compassionate & the Merciful.
Provider knowledge of California confidentiality laws: Associations with self-confidence and training Kapphahn C, MD, MPH 1, Rao S, MS, MPH 2, Jesser C,
OTIS ANNUAL RESEARCH MEETING JUNE 2010 Asthma and Asthma Medications in Pregnancy Study A Vaccines and Medications in Pregnancy Survelliance System (VAMPSS)
WIHS was established in 1993 to investigate the impact and progression of HIV in women.
California Chronic Care Learning Communities Initiative Collaborative Final Outcomes Congress December 9, 2005.
SARC: Participation and Protocol / Concept Review Robert Maki, MD PhD Memorial Sloan-Kettering Cancer Center.
Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.
Co-Director: Rahma Mungia, DDS, MSc.  What is Practice-Based Research Network (PBRN)?  Benefits of Participating in a PBRN  How to Engage Community.
Medical imaging Some funding opportunities Horizon 2020 topics PHC : Development of new diagnostic tools and technologies: in vivo medical imaging.
Incorporating Preconception Health into MCH Services
Melissa McCarey, MPH Jefferson Clinical Research Institute (JCRI) Clinicaltrials.gov: What is it? What do I need to know?
Understanding Clinical Trials – Part 2 Georgianne Arnold, MD Professor of Pediatrics University of Pittsburgh Medical Center Pittsburgh Children’s Hospital.
GI Working Group San Francisco ACR Saturday, November 8.
Clinical Research and Outcomes Registry Workshop Creating an Informed Consent Form Daniel Ford, MD, MPH Joseph Carrese, MD.
Personal Health Budgets Evaluation Evaluation of the Personal Health Budgets Pilots Wider Cohort Pilot Sites.
Managing Overseas Care in TCI-
Slide 1 Achieving National Quality Reporting Progress? Elliott S. Fisher, MD, MPH Professor of Medicine Center for the Evaluative Clinical Sciences Dartmouth.
PRIMA Investigator Meeting Friday, June 16, 2006 Grand Sofitel Demeure, Amsterdam Stéphanie Baulu, Delphine Germain & Gilles Salles.
Stakeholder Engagement for Patient-Centered Outcomes Research Vanessa Jacoby, MD, MAS Associate Professor Obstetrics, Gynecology, and Reproductive Sciences.
Speaking Clinical Trials Marianne Kearney Director of Research Operations Neurological Clinical Research Institute Massachusetts General Hospital.
Increased Patient Device Concerns But Not General Anxiety in Patients with a Secondary Indication for the ICD Susanne S. Pedersen, Professor of Cardiac.
Randomised Evaluation of Surgery with Craniectomy for patients Undergoing Evacuation of Acute Subdural Haematoma Contact: Arti Gulati Interim RESCUE-ASDH.
Regulatory and Reimbursement Harmonization An Industry Perspective Adrian Griffin | April 2016.
Study Development and Design Suzanne Adams RN MPH Director, Clinical Operations Jefferson Clinical Research Institute.
Symptom management with massage and acupuncture in post-operative cancer patients: A Randomized Controlled Study Wolf Mehling & Bradly Jacobs (PIs)
Duke Surgery Research Training Fellowship
Clinicaltrials.gov Update
Research Questions Does integration of behavioral health and primary care services, compared to simple co-location, improve patient-centered outcomes in.
Jeff Shuren, MD, JD Center for Devices and Radiological Health U. S
The Information Professional’s Role in Product Safety
Rare Disease Scholar’s Program: Equipping the Next Generation of Rare Disease Clinical Researchers to Be Successful Good morning. Thank you for having.
The FDA Early Feasibility Study Pilot and the Innovation Pathway
Thomas Mitchell, MA, MPH Department of Epidemiology & Biostatistics
Bozeman Health Clinical Research
Strategic & Operational Planning:
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Getting a Study Done at Jefferson:
September 7, 2018 Courtney Baird, MS
Society Perspective 07 SEPT 2018
PCORI Research Priorities and Relevant Examples
CONDUCTING THE TRIAL AT
Comparing Options for Management:PAtient-centered REsults for Uterine Fibroids Evan R. Myers, MD, MPH Department of Obstetrics & Gynecology and Duke Clinical.
Recruitment Video Storyboard Template
The world’s first standardized platform for data collection on burns
FDA Sentinel Initiative
Trial Funding and Engagement: The NIH Sponsored CTSA Program
Update on the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial A Multi-Center, Open-Label, Randomised Clinical Trial Comparing HIV Incidence.
Tobey Clark, Director*, Burlington USA
Sites in CEE A reliable place for clinical research?
MA STAAR Fall Learning Session Real-Time Handover Communication
REACHnet: Research Action for Health Network
Presentation transcript:

ULTRA (Uterine Leiomyoma Treatment with Radiofrequency Ablation) Vanessa Jacoby, MD, MAS Associate Professor Obstetrics, Gynecology, and Reproductive Sciences University of California, San Francisco Vanessa.Jacoby@ucsf.edu

ULTRA (Uterine Leiomyoma Treatment with Radiofrequency Ablation) AcessaTM is most recent FDA approved device to treat fibroids (November 2012) AcessaTM system enables laparoscopic radiofrequency ablation (RFA) of fibroids

ULTRA (Uterine Leiomyoma Treatment with Radiofrequency Ablation) Post-market observational cohort study to assess safety and effectiveness of women undergoing Acessa treatment Investigator-initiated, PI Dr. Vanessa Jacoby, UCSF Funded by Acessa Health under independent UCSF contract with no scientific input or data access by industry fibroids.ucsf.edu

ULTRA (Uterine Leiomyoma Treatment with Radiofrequency Ablation) Women enrolled in real-world practice settings across the country (primarily private practice) Recruitment: Phase 1: Voluntary referrals from clinicians (25 sites) Phase 2: “Engaged” clinical sites, standard multi-center study Study sites recruit and enroll: baseline visit prior to Acessa UCSF Coordinating Center does follow-up for 3 years after surgery Online consent and questionnaires (English and Spanish), sent via text message or email

ULTRA (Uterine Leiomyoma Treatment with Radiofrequency Ablation) Outcomes: Operative morbidity Change in fibroid symptoms (validated questionnaires) Treatment failure (need for fibroid surgery/procedure) Pregnancy outcomes Queried every 6 months with questionnaires (patient-reported outcomes) Medical records obtained at follow-up for repeat imaging

ULTRA (Uterine Leiomyoma Treatment with Radiofrequency Ablation) Collaborations Outcome assessment (CRFs and questionnaires) harmonized with COMPARE-UF NIH R01 submission Oct 2018 to include COMPARE-UF and ULTRA CRN: Opportunity to pilot new data elements in ongoing post-market device study